Tuesday, July 28, 2020 10:16:41 PM
Okay, now my quote is updated. While we wait for NNVC's next move, I'll share a quick story that kept my attention to trading.
And it really isn't about money.
not at all.
It's about tools.
So yes, it takes money to make a trade. But really, money IS THE TOOL. Take care of your tools. Keep them sharp. And if one breaks, DON'T get emotional about it, MOVE ON.
At the same time though, take an interest in where you're striking the axe. I would hate to strike right into a soft spot full of ants or termites. I need to know there's a solid foundation. And usually I can see that breezing through the latest 10k or publicly peer reviews to take a chance.
I think that's where NNVC is right now.
which works by trapping virus particles the same way as a Venus-fly-trap captures and consumes insects
https://finance.yahoo.com/news/nanoviricides-inc-raises-11-5-154800631.html
I quit writing for SA because their manipulation and lack of vetting but the article above qualifies for their platform. I don't know the authors of these articles posted but there is a relationship of some sorts between CEO and their "help" so to speak. Be careful with that.
https://seekingalpha.com/symbol/NNVC?s=nnvc
Just putting that in there since I'm
'm a 2 fingered typist.
in the end, the science is what matters, and if they can pull it off? That's what matters.
And it really isn't about money.
not at all.
It's about tools.
So yes, it takes money to make a trade. But really, money IS THE TOOL. Take care of your tools. Keep them sharp. And if one breaks, DON'T get emotional about it, MOVE ON.
At the same time though, take an interest in where you're striking the axe. I would hate to strike right into a soft spot full of ants or termites. I need to know there's a solid foundation. And usually I can see that breezing through the latest 10k or publicly peer reviews to take a chance.
I think that's where NNVC is right now.
which works by trapping virus particles the same way as a Venus-fly-trap captures and consumes insects
https://finance.yahoo.com/news/nanoviricides-inc-raises-11-5-154800631.html
I quit writing for SA because their manipulation and lack of vetting but the article above qualifies for their platform. I don't know the authors of these articles posted but there is a relationship of some sorts between CEO and their "help" so to speak. Be careful with that.
https://seekingalpha.com/symbol/NNVC?s=nnvc
Just putting that in there since I'm
'm a 2 fingered typist.
in the end, the science is what matters, and if they can pull it off? That's what matters.
Do your research! Play the TA. All posts are my opinion.
Is fundamental trading dead?
"We hope not." Richard Dennis
Recent NNVC News
- Deadly Measles Cases Accentuate the Need for a Treatment - NV-387 is Here to Help Patients and Control Spread, Says NanoViricides • ACCESS Newswire • 04/21/2026 12:30:00 PM
- Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides • ACCESS Newswire • 04/07/2026 12:30:00 PM
- Phase II Clinical Trial of Monkeypox Treatment by NV-387 to Commence Soon, Announces NanoViricides • ACCESS Newswire • 04/01/2026 12:30:00 PM
- NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete • ACCESS Newswire • 03/11/2026 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:30:47 PM
- MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/12/2026 01:30:00 PM
- Measles Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides • ACCESS Newswire • 02/10/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/30/2025 09:30:18 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 12/16/2025 09:30:05 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/15/2025 09:26:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 09:30:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:32:10 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 07:54:28 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/12/2025 04:29:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2025 09:07:54 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/29/2025 08:33:17 PM
